Publications by authors named "U Vitolo"

Claim this Profile
B
Better together: epcoritamab boosts R2 in FL.
Umberto Vitolo, Francesca Bonello

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.
Catherine Thieblemont, Maria Gomes Da Silva, Sirpa Leppä, Georg Lenz, Anne-Ségolène Cottereau, Umberto Vitolo

Hemasphere· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe.
Florence Broussais, Elise Pennings, Natacha Bolanos, Lorna Warwick, Robin Doeswijk, Umberto Vitolo

Hemasphere· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL).
Mattia Novo, Pio Manlio Mirko Frascione, Alessia Castellino, Luigi Marcheselli, Samantha Deianira Dattoli, Umberto Vitolo

Br J Haematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphoma.
Alessandra Rossi, Saveria Mazzara, Dorotea Salemi, Simone Zanetti, Maria Rosaria Sapienza, Umberto Vitolo

iScience· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis